.png){kind=icon}
我们可以帮助您解决与神经科学研究相关的科学、医学、运作和经济方面的挑战。
An experienced partner to navigate a complicated landscape
神经科学药物研发工作极具挑战性。由于存在较高的安慰剂反应率、极少的人类疾病生物标记物以及需要招募大量患者，加上报告方面的难题，获得疗法审批的过程充满风险。因此，您需要一个配备专门的神经科学专家和综合服务的可信赖合作伙伴，才能轻松应对这一不断演进的领域。
Utilize our deep experience at every stage of neuroscience drug development
Blaze a trail across the new paradigm in Alzheimer’s therapies
Understand the potential for abuse liability early in the nonclinical stages of the development process
神经系统疾病
- 阿尔茨海默病
- 帕金森氏症
- 癫痫
- Multiple sclerosis
Psychiatric disorders
- 躁郁症
- Major depression
- 精神分裂症
- Adult and pediatric sleep disorders
痛症
- 慢性
- 急性
- 偏头痛
Rare disorders
- Fragile X syndrome
- 杜尔雷斯综合症
- Morquio syndrome
- Pompe disease
A fresh, new approach to diseases like Alzheimer’s
We realize that our best chances of success lie in preventative measures for larger populations that may be at risk and don't present with symptoms-yet. 我们的团队率先采用创新的方法来招募并留住这些人士。此外，我们已开发出业内最渊博的知识库，可以找到具有最多成功机会的研究者。
From science to synapse
Our team is made up of experts in the specialty of neuroscience and neurologists-spanning both reasearch and development and clinical. 我们可以帮助您将非临床试验科学与临床试验研发阶段整合一起，在整个药物研发进程中实现可转换性并解决问题。
Effective strategies that keep the patient in mind
Understandably, the entire field of neuroscience is highly sensitive to risks that arise from noncompliance, controlled substance abuse and psychological instability. 我们利用自身广泛的研究者网络和综合的培训手段，从世界各地收集优质数据。我们不断通过生物标记物和成像技术开创更倚重实证的措施，从而减轻患者的负担。
Interconnected services across related diseases
我们为您的神经科学研发提供一整套全面的服务。该服务首先将为您配备非临床试验药理学和毒理学科学家，在这一快速变化的领域，他们是权威的思想领袖。 Add to that a wide array of biomarker and antibody products specific to neuroscience, along with core Phase I-IV development and testing services around the globe. And we integrate our commercialization services early in the process to maximize your return on investment the real world. 我们的一系列灵活服务包括：
让我们开始对话
联系我们